West Pharmaceutical Governance Vote Puts Leadership Structure And Valuation In Focus

A shareholder activist has proposed separating the CEO and Board Chair roles at West Pharmaceutical Services, a move coinciding with current CEO Eric M. Green’s announced retirement. Investors will vote on this proposal at the upcoming annual meeting, highlighting corporate governance and board independence. This development comes as the stock (NYSE:WST) has experienced mixed returns and is currently trading below analyst targets but above Simply Wall St’s fair value estimate.